Adherence to combination antiretroviral treatment and clinical outcomes in a Medicaid sample of older HIV-infected adults

被引:10
|
作者
Abara, Winston E. [1 ,3 ]
Adekeye, Oluwatoyosi A. [1 ]
Xu, Junjun [2 ]
Rust, George [2 ]
机构
[1] Morehouse Sch Med, Satcher Hlth Leadership Inst, Dept Community Hlth & Prevent Med, Atlanta, GA 30310 USA
[2] Morehouse Sch Med, Natl Ctr Primary Care, Atlanta, GA 30310 USA
[3] Satcher Hlth Leadership Inst, 720 Westview Dr SW,NCPC 214, Atlanta, GA 30310 USA
关键词
HIV; antiretroviral therapy; adherence; older adults; clinical outcomes; LESS-THAN; 95-PERCENT; ADMINISTRATIVE DATA; VIRAL SUPPRESSION; INHIBITOR THERAPY; INITIAL TREATMENT; FAILURE; REGIMEN; HAART; RATES; INTERVENTIONS;
D O I
10.1080/09540121.2016.1257774
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The adherence threshold for combination antiretroviral therapy (cART) has historically been set at 95% or greater. We examined whether different levels of cART adherence (>= 95% [optimal adherence], 90-94%, 80-89%, and <80%) were associated with different clinical outcomes (emergency department visits [ED visits] and duration of hospital admission) in a sample of older (50-64 years) persons living with HIV (PLWH). Medicaid data from 29 US states (n = 5177) were used for this study. cART adherence was measured and data regarding relevant covariates, such as race, sex, age, urbanicity, and comorbidity were obtained. Descriptive statistics were conducted to characterize study participants. We conducted univariate and multivariable regression analyses to evaluate the association between cART adherence and ED visits and duration of hospital admission while adjusting for covariates (race, sex, age, urbanicity, and comorbidity). Approximately 32% of all participants (n = 5177) reported optimal cART adherence (>= 95%). After adjusting for covariates, only participants who reported <80% adherence were more likely to have an ED visit (adjusted odds ratio = 1.34, 95% CI = 1.08-1.48, p <.0001) and a longer duration of hospital admission (regression coefficient = 1.24, 95% CI = 0.53-1.96, p =.0007) when compared to participants who reported >= 95% adherence. There were no significant differences in likelihood of having an ED visit and longer duration of hospital admission between participants who reported >= 95% adherence and participants who reported 90-94% adherence and 80-89% adherence. Significant differences by covariates were observed. Adverse clinical outcomes were associated with low cART adherence (<80%) among older PLWH, though they did not differ between optimal and moderate cART adherence (90-94% and 80-89%). Although optimal cART adherence is an important goal, clinical outcomes in older PLWH may not differ between moderate and optimal cART adherence.
引用
收藏
页码:441 / 448
页数:8
相关论文
共 50 条
  • [1] Antiretroviral Treatment Efficacy and Safety in Older HIV-Infected Adults
    Jourjy, Jacqueline
    Dahl, Keelin
    Huesgen, Emily
    [J]. PHARMACOTHERAPY, 2015, 35 (12): : 1140 - 1151
  • [2] ANTIRETROVIRAL THERAPY INTERRUPTION AND CLINICAL OUTCOMES IN HIV-INFECTED ADULTS
    Mgbere, Osaro
    Barahmani, Nadia
    Wang, Jason
    Khuwaja, Salma
    Essien, Ekere James
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2019, 15 (10): : E39 - E39
  • [3] Antiretroviral adherence and use of alternative therapies among older HIV-infected adults
    Wutoh, AK
    Brown, CM
    Kumoji, EK
    Daftary, MS
    Jones, T
    Barnes, NA
    Powell, NJ
    [J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2001, 93 (7-8) : 243 - 250
  • [4] Clinical characteristics and antiretroviral treatment of older HIV-infected patients
    Mercedes Gimeno-Gracia
    María José Crusells-Canales
    María José Rabanaque-Hernández
    [J]. International Journal of Clinical Pharmacy, 2014, 36 : 1190 - 1195
  • [5] Clinical characteristics and antiretroviral treatment of older HIV-infected patients
    Gimeno-Gracia, Mercedes
    Jose Crusells-Canales, Maria
    Jose Rabanaque-Hernandez, Maria
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2014, 36 (06) : 1190 - 1195
  • [6] Barriers to antiretroviral adherence among HIV-infected adults
    Murphy, DA
    Roberts, KJ
    Martin, DJ
    Marelich, W
    Hoffman, D
    [J]. AIDS PATIENT CARE AND STDS, 2000, 14 (01) : 47 - 58
  • [7] Predicting Adherence to Antiretroviral Therapy in HIV-Infected Older Adults: The Moderating Role of Gender
    Joseph A. Bianco
    Timothy G. Heckman
    Mark Sutton
    Rewadee Watakakosol
    Travis Lovejoy
    [J]. AIDS and Behavior, 2011, 15 : 1437 - 1446
  • [8] Predicting Adherence to Antiretroviral Therapy in HIV-Infected Older Adults: The Moderating Role of Gender
    Bianco, Joseph A.
    Heckman, Timothy G.
    Sutton, Mark
    Watakakosol, Rewadee
    Lovejoy, Travis
    [J]. AIDS AND BEHAVIOR, 2011, 15 (07) : 1437 - 1446
  • [9] Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies
    Braithwaite, R. Scott
    Kozal, Michael J.
    Chang, Chung Chou H.
    Roberts, Mark S.
    Fultz, Shawn L.
    Goetz, Matthew Bidwell
    Gibert, Cynthia
    Rodriguez-Barradas, Maria
    Mole, Larry
    Justice, Amy C.
    [J]. AIDS, 2007, 21 (12) : 1579 - 1589
  • [10] Correlates of Combination Antiretroviral Adherence Among Recently Diagnosed Older HIV-Infected Adults Between 50 and 64 years
    Abara, Winston E.
    Adekeye, Oluwatoyosi A.
    Xu, Junjun
    Heiman, Harry J.
    Rust, George
    [J]. AIDS AND BEHAVIOR, 2016, 20 (11) : 2674 - 2681